Continuing Treatment for Participants Who Have Participated in a Prior Protocol Investigating Elotuzumab
Clinical trial NCT02719613 · COMPLETED
Trial details
- NCT number
- NCT02719613
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-15
- Primary completion
- 2026-02-23
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.